Non-pharmacologic approaches for hidradenitis suppurativa – a systematic review

References

• Ring HC, Bay L, Nilsson M, et al. Bacterial biofilm in chronic lesions of hidradenitis suppurativa. Br J Dermatol. 2017;176:993–1000.
   PubMed Web of Science ®Google Scholar
• Gooderham M, Papp K. The psychosocial impact of hidradenitis suppurativa. J Am Acad Dermatol. 2015;73:S19–S22.
   PubMed Web of Science ®Google Scholar
• Smith MK, Nicholson CL, Parks-Miller A, et al. Hidradenitis suppurativa: an update on connecting the tracts. F1000Res. 2017;6:1272.
   PubMedGoogle Scholar
• Ernst E. The usage of complementary therapies by dermatological patients: a systematic review. Brit J Dermatol. 2000;142:857–861.
   PubMed Web of Science ®Google Scholar
• OCEBM Levels of Evidence Working Group. The Oxford Levels of Evidence 2: Oxford Centre for Evidence-Based Medicine. [cited 2019 May 24] Available from: https://www.cebm.net/index.aspx?o=5653
   Google Scholar
• Alavi A, Kirsner RS. Local wound care and topical management of hidradenitis suppurativa. J Am Acad Dermatol. 2015;73:S55–S61.
   PubMed Web of Science ®Google Scholar
• von der Werth JM, Williams HC. The natural history of hidradenitis suppurativa. J Eur Acad Dermatol Venerol. 2000;14:389–392.
   PubMed Web of Science ®Google Scholar
• Paletta C, Jurkiewicz MJ. Hidradenitis suppurativa. Clin Plastic Surg. 1987;14:383–390.
   PubMed Web of Science ®Google Scholar
• Leung TH, Zhang LF, Wang J, et al. Topical hypochlorite ameliorates NF-kappaB-mediated skin diseases in mice. J Clin Invest. 2013;123:5361–5370.
   PubMed Web of Science ®Google Scholar
• Fukuyama T, Martel BC, Linder KE, et al. Hypochlorous acid is antipruritic and anti-inflammatory in a mouse model of atopic dermatitis. Clin Exp Allergy. 2018;48:78–88.
   PubMed Web of Science ®Google Scholar
• Shah N. Hidradenitis suppurativa: a treatment challenge. Am Fam Physician. 2005;72:1547–1552.
   PubMed Web of Science ®Google Scholar
• Humphries LS, Kueberuwa E, Beederman M, et al. Wide excision and healing by secondary intent for the surgical treatment of hidradenitis suppurativa: a single-center experience. J Plastic Reconstruc Aesthet Surg. 2016;69:554–566.
   PubMed Web of Science ®Google Scholar
• Sellheyer K, Krahl D. "Hidradenitis suppurativa" is acne inversa! An appeal to (finally) abandon a misnomer. Int J Dermatol. 2005;44:535–540.
   PubMed Web of Science ®Google Scholar
• van der Zee HH, Laman JD, Boer J, et al. Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments. Exp Dermatol. 2012;21:735–739.
   PubMed Web of Science ®Google Scholar
• Kurzen H, Kurokawa I, Jemec GB, et al. What causes hidradenitis suppurativa? Exp Dermatol. 2008;17:455–456.
   PubMed Web of Science ®Google Scholar
• Matusiak L, Bieniek A, Szepietowski JC. Hidradenitis suppurativa and associated factors: still unsolved problems. J Am Acad Dermatol. 2009;61:362–365.
   PubMed Web of Science ®Google Scholar
• Morgan WP, Leicester G. The role of depilation and deodorants in hidradenitis suppurativa. Arch Dermatol. 1982;118:101–102.
   PubMedGoogle Scholar
• Bettoli V, Naldi L, Cazzaniga S, et al. Overweight, diabetes and disease duration influence clinical severity in hidradenitis suppurativa-acne inversa: evidence from the national Italian registry. Br J Dermatol. 2016;174:195–197.
   PubMed Web of Science ®Google Scholar
• Canoui-Poitrine F, Revuz JE, Wolkenstein P, et al. Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity. J Am Acad Dermatol. 2009;61:51–57.
   PubMed Web of Science ®Google Scholar
• Crowley JJ, Mekkes JR, Zouboulis CC, et al. Association of hidradenitis suppurativa disease severity with increased risk for systemic comorbidities. Br J Dermatol. 2014;171:1561–1565.
   PubMed Web of Science ®Google Scholar
• Sartorius K, Emtestam L, Jemec GB, et al. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity. Br J Dermatol. 2009;161:831–839.
   PubMed Web of Science ®Google Scholar
• Schrader AM, Deckers IE, van der Zee HH, et al. Hidradenitis suppurativa: a retrospective study of 846 Dutch patients to identify factors associated with disease severity. J Am Acad Dermatol. 2014;71:460–467.
   PubMed Web of Science ®Google Scholar
• Shalom G, Freud T, Harman-Boehm I, et al. Hidradenitis suppurativa and metabolic syndrome: a comparative cross-sectional study of 3207 patients. Br J Dermatol. 2015;173:464–470.
   PubMed Web of Science ®Google Scholar
• Boer J, Nazary M, Riis PT. The role of mechanical stress in hidradenitis suppurativa. Dermatol Clin. 2016;34:37–43.
   PubMed Web of Science ®Google Scholar
• Boer J. Should hidradenitis suppurativa be included in dermatoses showing koebnerization? is it friction or fiction? Dermatology. 2017;233:47–52.
   PubMed Web of Science ®Google Scholar
• Maher M, Larsen L. A case of radiation-induced localized exacerbation of hidradenitis suppurativa. JAAD Case Rep. 2016;2:44–46.
   PubMedGoogle Scholar
• Dufour DN, Bryld LE, Jemec GB. Hidradenitis suppurativa complicating naevus comedonicus: the possible influence of mechanical stress on the development of hidradenitis suppurativa. Dermatology. 2010;220:323–325.
   PubMed Web of Science ®Google Scholar
• Rondags A, Diercks GF, Werker PMN, et al. Ectopic hidradenitis suppurativa on the dorsal foot of a road maker. JAAD Case Rep. 2017;3:429–431.
   PubMedGoogle Scholar
• de Winter K, van der Zee HH, Prens EP. Is mechanical stress an important pathogenic factor in hidradenitis suppurativa? Exp Dermatol. 2012;21:176–177.
   PubMed Web of Science ®Google Scholar
• Boer J, Mihajlovic D. Boils at frictional locations in a patient with hidradenitis suppurativa. Acta Dermatovenerol Croat. 2016;24:303–304.
   PubMed Web of Science ®Google Scholar
• Zouboulis CC, Desai N, Emtestam L, et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol. 2015;29:619–644.
   PubMed Web of Science ®Google Scholar
• Boer J. Does obesity cause a distinct phenotype of hidradenitis suppurativa? J Eur Acad Dermatol Venereol. 2018;32:e195–e196.
   PubMed Web of Science ®Google Scholar
• Patil S, Apurwa A, Nadkarni N, et al. Hidradenitis suppurativa: inside and out. Indian J Dermatol. 2018;63:91–98.
   PubMed Web of Science ®Google Scholar
• Miller IM, Rytgaard H, Mogensen UB, et al. Body composition and basal metabolic rate in hidradenitis suppurativa: a Danish population-based and hospital-based cross-sectional study. J Eur Acad Dermatol Venereol. 2016;30:980–988.
   PubMed Web of Science ®Google Scholar
• Gold DA, Reeder VJ, Mahan MG, et al. The prevalence of metabolic syndrome in patients with hidradenitis suppurativa. J Am Acad Dermatol. 2014;70:699–703.
   PubMed Web of Science ®Google Scholar
• Sabat R, Chanwangpong A, Schneider-Burrus S, et al. Increased prevalence of metabolic syndrome in patients with acne inversa. PLoS One. 2012;7:e31810.
   PubMed Web of Science ®Google Scholar
• Boer J. Resolution of hidradenitis suppurativa after weight loss by dietary measures, especially on frictional locations. J Eur Acad Dermatol Venereol. 2016;30:895–896.
   PubMed Web of Science ®Google Scholar
• Kromann CB, Ibler KS, Kristiansen VB, et al. The influence of body weight on the prevalence and severity of hidradenitis suppurativa. Acta Derm Venerol. 2014;94:553–557.
   PubMed Web of Science ®Google Scholar
• Thomas CL, Gordon KD, Mortimer PS. Rapid resolution of hidradenitis suppurativa after bariatric surgical intervention. Clin Exp Dermatol. 2014;39:315–317.
   PubMed Web of Science ®Google Scholar
• Gill L, Williams M, Hamzavi I. Update on hidradenitis suppurativa: connecting the tracts. F1000Prime Rep. 2014;6:112.
   PubMedGoogle Scholar
• Jamal A, Phillips E, Gentzke AS, et al. Current cigarette smoking among adults – United States, 2016. MMWR Morb Mortal Wkly Rep. 2018;67:53–59.
   PubMed Web of Science ®Google Scholar
• Woodruff CM, Charlie AM, Leslie KS. Hidradenitis suppurativa: a guide for the practicing physician. Mayo Clin Proc. 2015;90:1679–1693.
   PubMed Web of Science ®Google Scholar
• Konig A, Lehmann C, Rompel R, et al. Cigarette smoking as a triggering factor of hidradenitis suppurativa. Dermatology. 1999;198:261–264.
   PubMed Web of Science ®Google Scholar
• Revuz JE, Canoui-Poitrine F, Wolkenstein P, et al. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol. 2008;59:596–601.
   PubMed Web of Science ®Google Scholar
• Kromann CB, Deckers IE, Esmann S, et al. Risk factors, clinical course and long-term prognosis in hidradenitis suppurativa: a cross-sectional study. Br J Dermatol. 2014;171:819–824.
   PubMed Web of Science ®Google Scholar
• Lapins J, Asman B, Gustafsson A, et al. Neutrophil-related host response in hidradenitis suppurativa: a pilot study in patients with inactive disease. Acta Derm Venereol. 2001;81:96–99.
   PubMed Web of Science ®Google Scholar
• Parks RW, Parks TG. Pathogenesis, clinical features and management of hidradenitis suppurativa. Ann R Coll Surg Engl. 1997;79:83–89.
   PubMedGoogle Scholar
• Matusiak Ɫ, Szczęch J, Kaaz K, et al. Clinical characteristics of pruritus and pain in patients with hidradenitis suppurativa. Acta Derm Venerol. 2018;98:191–194.
   PubMed Web of Science ®Google Scholar
• Kaaz K, Szepietowski JC, Matusiak L. Influence of itch and pain on sleep quality in patients with hidradenitis suppurativa. Acta Derm Venereol. 2018;98:757–761.
   PubMed Web of Science ®Google Scholar
• Shavit E, Dreiher J, Freud T, et al. Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2015;29:371–376.
   PubMed Web of Science ®Google Scholar
• Kouris A, Platsidaki E, Christodoulou C, et al. Quality of life and psychosocial implications in patients with hidradenitis suppurativa. Dermatology. 2016;232:687–691.
   PubMed Web of Science ®Google Scholar
• von Laffert M, Helmbold P, Wohlrab J, et al. Hidradenitis suppurativa (acne inversa): early inflammatory events at terminal follicles and at interfollicular epidermis. Exp Dermatol. 2009;19:533–537.
   PubMed Web of Science ®Google Scholar
• von Laffert M, Stadie V, Wohlrab J, et al. Hidradenitis suppurativa/acne inversa: bilocated epithelial hyperplasia with very different sequelae. Br J Dermatol. 2011;164:367–371.
   PubMed Web of Science ®Google Scholar
• Maggini S, Wintergerst ES, Beveridge S, et al. Selected vitamins and trace elements support immune function by strengthening epithelial barriers and cellular and humoral immune responses. Br J Nutr. 2007;98:S29–S35.
   PubMed Web of Science ®Google Scholar
• Mortimore M, Florin TH. A role for B(1)(2) in inflammatory bowel disease patients with suppurative dermatoses? An experience with high dose vitamin B(1)(2) therapy. J Crohns Colitis. 2010;4:466–470.
   PubMed Web of Science ®Google Scholar
• Watson WH, Zhao Y, Chawla RS. Adenosylmethionine attenuates the lipopolysaccharide-induced expression of the gene for tumour necrosis factor alpha. Biochem J. 1999;342:21–25.
   PubMed Web of Science ®Google Scholar
• Melnik BC, Plewig G. Impaired Notch-MKP-1 signalling in hidradenitis suppurativa: an approach to pathogenesis by evidence from translational biology. Exp Dermatol. 2013;22:172–177.
   PubMed Web of Science ®Google Scholar
• Giamarellos-Bourboulis EJ, Antonopoulou A, Petropoulou C, et al. Altered innate and adaptive immune responses in patients with hidradenitis suppurativa. Br J Dermatol. 2007;156:51–56.
   PubMed Web of Science ®Google Scholar
• Dreno B, Khammari A, Brocard A, et al. Hidradenitis suppurativa: the role of deficient cutaneous innate immunity. Arch Dermatol. 2012;148:182–186.
   PubMedGoogle Scholar
• Schlapbach C, Yawalkar N, Hunger RE. Human beta-defensin-2 and psoriasin are overexpressed in lesions of acne inversa. J Am Acad Dermatol. 2009;61:58–65.
   PubMed Web of Science ®Google Scholar
• Hofmann SC, Saborowski V, Lange S, et al. Expression of innate defense antimicrobial peptides in hidradenitis suppurativa. J Am Acad Dermatol. 2012;66:966–974.
   PubMed Web of Science ®Google Scholar
• Demay MB. The hair cycle and Vitamin D receptor. Arch Biochem Biophys. 2012;523:19–21.
   PubMed Web of Science ®Google Scholar
• Amor KT, Rashid RM, Mirmirani P. Does D matter? The role of vitamin D in hair disorders and hair follicle cycling. Dermatol Online J. 2010;16:3–20178699.
   PubMedGoogle Scholar
• Guillet A, Brocard A, Bach Ngohou K, et al. Verneuil's disease, innate immunity and vitamin D: a pilot study. J Eur Acad Dermatol Venereol. 2015;29:1347–1353.
   PubMed Web of Science ®Google Scholar
• Brocard A, Dreno B. Innate immunity: a crucial target for zinc in the treatment of inflammatory dermatosis. J Eur Acad Dermatol Venereol. 2011;25:1146–1152.
   PubMed Web of Science ®Google Scholar
• Kitabayashi C, Fukada T, Kanamoto M, et al. Zinc suppresses Th17 development via inhibition of STAT3 activation. Int Immunol. 2010;22:375–386.
   PubMed Web of Science ®Google Scholar
• Dreno B, Trossaert M, Boiteau HL, et al. Zinc salts effects on granulocyte zinc concentration and chemotaxis in acne patients. Acta Derm Venereol. 1992;72:250–252.
   PubMed Web of Science ®Google Scholar
• Lima AL, Karl I, Giner T, et al. Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa. Br J Dermatol. 2016;174:514–521.
   PubMed Web of Science ®Google Scholar
• Jarrousse V, Castex-Rizzi N, Khammari A, et al. Zinc salts inhibit in vitro Toll-like receptor 2 surface expression by keratinocytes. Eur J Dermatol. 2007;17:492–496.
   PubMed Web of Science ®Google Scholar
• Kim J, Ochoa MT, Krutzik SR, et al. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol (Baltimore, Md: 1950). 2002;169:1535–1541.
   PubMed Web of Science ®Google Scholar
• Hunger RE, Surovy AM, Hassan AS, et al. Toll-like receptor 2 is highly expressed in lesions of acne inversa and colocalizes with C-type lectin receptor. Br J Dermatol. 2008;158:691–697.
   PubMed Web of Science ®Google Scholar
• Brocard A, Knol AC, Khammari A, et al. Hidradenitis suppurativa and zinc: a new therapeutic approach. A pilot study. Dermatology. 2007;214:325–327.
   PubMed Web of Science ®Google Scholar
• Hessam S, Sand M, Meier NM, et al. Combination of oral zinc gluconate and topical triclosan: an anti-inflammatory treatment modality for initial hidradenitis suppurativa. J Dermatol Sci. 2016;84:197–202.
   PubMed Web of Science ®Google Scholar
• Barrie SA, Wright JV, Pizzorno JE, et al. Comparative absorption of zinc picolinate, zinc citrate and zinc gluconate in humans. Agents Actions. 1987;21:223–228.
   PubMedGoogle Scholar
• Institute of Medicine. Food and Nutrition Board. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium and Zinc. Washington, DC: National Academy Press; 2001.
   Google Scholar
• Duncan A, Yacoubian C, Watson N, et al. The risk of copper deficiency in patients prescribed zinc supplements. J Clin Pathol. 2015;68:723–725.
   PubMed Web of Science ®Google Scholar
• Myint ZW, Oo TH, Thein KZ, et al. Copper deficiency anemia: review article. Ann Hematol. 2018;97:1527–1534.
   PubMed Web of Science ®Google Scholar
• Barrea L, Fabbrocini G, Annunziata G, et al. Role of nutrition and adherence to the mediterranean diet in the multidisciplinary approach of hidradenitis suppurativa: evaluation of nutritional status and its association with severity of disease. Nutrients. 2018;11:57.
   Web of Science ®Google Scholar
• Lazo-Velez MA, Serna-Saldivar SO, Rosales-Medina MF, et al. Application of Saccharomyces cerevisiae var. boulardii in food processing: a review. J Appl Microbiol. 2018;125:943–951.
   PubMed Web of Science ®Google Scholar
• Cannistra C, Finocchi V, Trivisonno A, et al. New perspectives in the treatment of hidradenitis suppurativa: surgery and brewer's yeast-exclusion diet. Surgery. 2013;154:1126–1130.
   PubMed Web of Science ®Google Scholar
• Colboc HF, Cannistra C, Chaby G, et al. Interest of brewer's yeast-exclusion diet in the management of hidradenitis suppurativa. J Clin Exp Dermatol Resh. 2016;7:5.
   Google Scholar
• Zhang Z, Li C, Zhao X, et al. Anti-Saccharomyces cerevisiae antibodies associate with phenotypes and higher risk for surgery in Crohn's disease: a meta-analysis. Dig Dis Sci. 2012;57:2944–2954.
   PubMed Web of Science ®Google Scholar
• Coukos JA, Howard LA, Weinberg JM, et al. ASCA IgG and CBir antibodies are associated with the development of Crohn's disease and fistulae following ileal pouch-anal anastomosis. Dig Dis Sci. 2012;57:1544–1553.
   PubMed Web of Science ®Google Scholar
• Russell RK, Ip B, Aldhous MC, et al. Anti-Saccharomyces cerevisiae antibodies status is associated with oral involvement and disease severity in Crohn disease. J Pediatr Gastroenterol Nutr. 2009;48:161–167.
   PubMed Web of Science ®Google Scholar
• Hassoun LA, Ornelas JN, Sivamani RK. Cedarwood oil as complementary treatment in refractory acne. J Alter Complement Med (New York, NY). 2016;22:252–253.
   PubMed Web of Science ®Google Scholar
• Sahebkar A, Cicero AFG, Simental-Mendia LE, et al. Curcumin downregulates human tumor necrosis factor-alpha levels: a systematic review and meta-analysis ofrandomized controlled trials. Pharmacol Res. 2016;107:234–242.
   PubMed Web of Science ®Google Scholar